Study of Nivolumab for Advanced Cancers in India

Clinical trial NCT03444766 · COMPLETED

Trial details

NCT number: NCT03444766
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer (NSCLC)Non-Small-Cell Lung Carcinoma Nonsmall Cell Lung Cancer Kidney Cancer Kidney Neoplasms Renal Cancer Renal Neoplasms

Start date: 2018-03-06
Primary completion: 2019-07-17
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.